What’s new: SE’s reported 1Q25 top-line results that were below consensus and our expectations. However, margins beat expectations partly driven by continued cost controls and a rational market environment. All major business segments could remain resilient, while margins could fluctuate QoQ depending on seasonality. We up our PT from USD160 to USD180 on improving margin outlook. Our revised PT of USD180 implies 4.9x FY25E EV/Rev. We maintain our BUY rating. Analysts: Jin Yoon
KEY HIGHLIGHTS Results Food Empire Holdings (FEH SP/BUY/S$1.53/Target: S$1.98) 1Q25: A strong start and a more optimistic outlook; raise target price by 65%. RH Petrogas (RHP SP/BUY/S$0.146/Target: S$0.254) 1Q25: Strong cost control and rising free cash flow with exploration wells to look forward to in 2H25. Maintain BUY. SEA (SE US/BUY/US$154.13/Target: US$181.64) 1Q25: Strong earnings from better operating le...
GREATER CHINA Strategy China And Hong Kong Property & Hong Kong Landlord Tariffs curtail US rate cuts, thereby hindering the recovery of Hong Kong property and tourism; Maintain OVERWEIGHT on China property. INDONESIA Strategy Alpha Picks: Outperform In Mar 25 Remove BBNI, BBRI, ASII, JSMR and KLBF; add BBCA, ICBP, ERAA and BUKA. MALAYSIA Update Pekat Group (PEKAT MK/BUY/RM1.08/Target: RM1.45) Good earnings visibility over 2025...
The selloff driven by the US’ unprecedented and perplexing tariff plans has liberated many investors of profits this year. Given the fluidity of market conditions, we highlight a number of domestic-focused stocks such as CENT, CD, DFI, HLA, PANU, PROP, RFMD, SSG and SIE as well as Singapore-focused REITS such as CDLHT, FEHT, FCT, KREIT, LREIT and PREIT. In addition, the MAS’ equity market review should inject much needed liquidity in 2H25. We lower our STI target to 3,720 (previously 4,115).
What’s new: SE’s reported 4Q24 results that were above consensus and our expectations. All major business segments could remain resilient, while margins could further improve in 2025 partly driven by a more rational market environment. We up our PT from USD130 to USD160 on improving outlook. Our revised PT of USD160 implies 3.9x FY25E EV/Rev. We maintain our BUY rating. Analysts: Jin Yoon
KEY HIGHLIGHTS Results RH Petrogas (RHP SP/BUY/S$0.156/Target: S$0.254) 2024: Cost control the highlight with two wells to watch in July. Maintain BUY. SEA (SE US/BUY/US$123.49/Target: US$153.11) 2024: Results above expectations; strong growth outlook for 2025. TRADERS' CORNER UMS Holdings (UMSH SP): Trading BUY Propnex (PROP SP): Trading BUY
KEY HIGHLIGHTS Results CapitaLand Ascott Trust (CLAS SP/BUY/S$0.88/Target: S$1.38): 2H24: Portfolio reconstitution starting to bear fruit. Update SEA (SE US/BUY/US$117.79/Target: US$138.70): 4Q24 results preview: Growth across all segments, but expect some forex drag. TRADERS’ CORNER DFI Retail Group Holdings (DFI SP): Trading SELL Jardine Cycle & Carriage (JCNC SP): Trading SELL
What’s new: SE’s reported 3Q24 results that were above consensus and our expectations. Shopee FY24 GMV growth guidance remains intact, while Free Fire FY24 bookings could grow over 30% YoY. We up our PT from USD120 to USD130 on improving outlook. Our revised PT of USD130 implies 3.7x FY25E EV/Rev. We maintain our BUY rating. Analysts: Jin Yoon
GREATER CHINA Small-mid Cap Highlight Modern Dental (3600 HK/NOT RATED/HK$3.68): Leading global provider of dental prosthetics devices. INDONESIA Update Indocement Tunggal Prakarsa (INTP IJ/BUY/Rp7,050/Target: Rp7,800): Expect earnings to recover 8.1% in 2025. Upgrade to BUY. MALAYSIA Results Hartalega Holdings (HART MK/BUY/RM3.32/Target: RM3.66): 2QFY25: Weak headline numbers due to forex losses, but operating matrixes chart strong growth. Maintain BUY with unchanged target price of RM3.66. H...
KEY HIGHLIGHTS Results Lendlease Global Commercial REIT (LREIT SP/BUY/S$0.57/Target: S$0.77) 1QFY25: Resiliency from Singapore; progressively backfilling Building 3 in Milan. Riverstone Holdings (RSTON SP/BUY/S$0.90/Target: S$1.16) 3Q24: Results in line; healthy outlook ahead with capacity expansion. SEA (SE US/BUY/US$107.65/Target: US$138.70) 3Q24: Robust quarter as Shopee returns to profitability. MONTHLY TECHNICAL - INDICES OUTLOOK FTSE Straits Times Index (STI IND): Bullish price trend...
What’s New: We up our 3Q estimates as key segments such as gaming, e-commerce and fintech could continue to see positive momentum. Shopee EBITDA could potentially turn positive in 3Q as increase in take rates could partly offset the promotional spending in the quarter. We up our PT from USD85 to USD120 on upward revision in forward estimates. Our updated PT of USD120 implies 3.5x FY25E EV/Revs. We maintain our BUY rating. Analysts: Jin Yoon
After Powell’s Jackson Hole speech on 23 August, we see a turning point starting with a US Fed rate cut in Sep 24 and lower rates heading into 2025. In the Singapore market, REITs and the property sector should benefit, as should highly-geared companies and those looking to recycle capital. Our current forecasts have incorporated lower NIMs for banks which we believe are protected by their high dividend yields.
What’s new: SE’s reported 2Q24 results that were above consensus and our expectations. Shopee will reach adjusted EBITDA positive in 3Q24 and Shopee GMV growth could reach mid-20% in FY24. Garena could also reach double digit user and bookings growth in FY24 despite weaker seasonality in 2H. We up our PT from USD75 to USD85 on improving outlook. Our revised PT of USD85 implies 2.5x FY25E EV/Rev. We maintain our BUY rating. Analysts: Jin Yoon
KEY HIGHLIGHTS Results CapitaLand Integrated Commercial Trust (CICT SP/BUY/S$2.10/Target: S$2.29): 1H24: Stable occupancies; smooth execution for AEIs. SEA (SE US/BUY/US$74.85/Target: US$88.21): 2Q24: Strong quarter, improving outlook and better profit profile. UMS Holdings (UMSH SP/SELL/S$1.07/Target:S$0.90): 2Q24: Earnings below expectations due to forex; slow ramp-up of new customer. Wilmar International (WIL SP/HOLD/S$3.01/Target: S$3.25): 1H24: Results in line with expectations. Higher ...
GREATER CHINA Economics Money Supply Weak demand for transactional funds and medium- to long-term loans. Results Foxconn Industrial Internet (601138 CH/BUY/Rmb20.78/Target: Rmb30.00) 2Q24: Solid progress in AI business; margin misses due to product mix changes. Sino Biopharmaceutical (1177 HK/BUY/HK$2.95/Target: HK$4.00) 1H24: Results beat; expects double-digit revenue and earnings growth in 2024. INDONESIA Update In...
What’s new: SE’s reported 1Q24 results were above consensus and our expectations. E-commerce could remain resilient where Shopee adjusted EBITDA is on track to turn positive in 2H24. We up our PT from USD70 to USD75 on improving margin outlook. Our revised PT of USD75 implies 2.5x FY25E EV/Rev. We maintain our BUY rating. Analysts: Jin Yoon
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.